Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma
Clinical trial NCT01215565 · TERMINATED
Trial details
- NCT number
- NCT01215565
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.